Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Inozyme Pharma Inc shares valued at $52,210 were sold by Treco Douglas A on Apr 02 ’24. At $6.94 per share, Treco Douglas A sold 7,523 shares. The insider’s holdings dropped to 20,665 shares worth approximately $94645.7 following the completion of this transaction.
Also, Hopfner Robert Lorne purchased 833,333 shares, netting a total of over 3,999,998 in proceeds. Following the buying of shares at $4.80 each, the insider now holds 2,923,110 shares.
Before that, Pivotal bioVenture Partners Fu had added 833,333 shares to its account. In a trade valued at $3,999,998, the Director bought Inozyme Pharma Inc shares for $4.80 each. Upon closing the transaction, the insider’s holdings increased to 833,333 shares, worth approximately $13.39 million.
As published in a research note from Jefferies on March 23, 2023, Inozyme Pharma Inc [INZY] has been rated up from a Hold to a Buy and the price target has been revised to $6 from $4.50. Analysts at Jefferies started covering the stock with ‘”a Hold”‘ outlook in a report released in late May. As of February 07, 2022, H.C. Wainwright has initiated its “Buy” rating for INZY. Earlier on November 29, 2021, Needham initiated its rating. Their recommendation was “a Buy” for INZY stock.
Analyzing INZY Stock Performance
During the last five days, there has been a drop of approximately -12.26%. Over the course of the year, Inozyme Pharma Inc shares have jumped approximately 7.51%. Shares of the company reached a 52-week high of $7.80 on 04/01/24 and a 52-week low of $4.03 on 01/17/24. A 50-day SMA is recorded $5.95, while a 200-day SMA reached $4.77. Nevertheless, trading volume fell to 0.56 million shares from 0.7 million shares the previous day.
Support And Resistance Levels for Inozyme Pharma Inc (INZY)
According to the 24-hour chart, there is a support level at 4.49, which, if violated, would cause prices to drop to 4.41. In the upper region, resistance lies at 4.74. The next price resistance is at 4.91. RSI (Relative Strength Index) is 32.83 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.02, which suggests the price will decrease in the coming days. Percent R is at 99.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
